NeuroLucent Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 4

NeuroLucent General Information

Description

Developer of ryanodine receptor drugs designed to treat Alzheimer's disease. The company's drugs stabilizes dysregulated calcium signaling within brain cells in patients with early Alzheimer's or mild cognitive impairment, enabling patients to restore healthy neuronal signaling and keep synaptic health and memory function intact.

Contact Information

Website
www.neurolucent.com
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 1261 Oak Knoll Drive
  • Lake Forest, IL 60045
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1261 Oak Knoll Drive
  • Lake Forest, IL 60045
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroLucent Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroLucent‘s full profile, request access.

Request a free trial

NeuroLucent Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NeuroLucent‘s full profile, request access.

Request a free trial

NeuroLucent FAQs

  • When was NeuroLucent founded?

    NeuroLucent was founded in 2016.

  • Where is NeuroLucent headquartered?

    NeuroLucent is headquartered in Lake Forest, IL.

  • What industry is NeuroLucent in?

    NeuroLucent’s primary industry is Drug Discovery.

  • Is NeuroLucent a private or public company?

    NeuroLucent is a Private company.

  • What is NeuroLucent’s current revenue?

    The current revenue for NeuroLucent is .

  • Who are NeuroLucent’s investors?

    National Institute on Aging has invested in NeuroLucent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process